Linda Tharby

Chief Executive Officer and President, Director since 2022

Ms. Tharby has served as the Company’s Chief Executive Officer since April 2021. Ms. Tharby has over 25 years of executive leadership experience building and leading strong performing global organizations that develop and commercialize products and service innovations, while delivering solutions to patients in the home setting. Prior to joining the Company, Ms. Tharby spent the last 24 years working in various roles of increased responsibility at Becton Dickinson (“BD”). Ms. Tharby was a member of the Executive Leadership team of BD that transformed the company from an $8 billion medical supplies company to an $18 billion global medical technology company. Ms. Tharby’s most recent role at BD was Chief Customer Experience Officer from July 2018 through December 2020. In her prior role, as BD’s Chief Human Resources Officer, from October 2016 through July 2018, she led the company through its $24 billion acquisition and integration of C.R. Bard in 2017. She also held numerous global business leadership roles at BD, including Executive Vice President and President of Life Sciences, Group President of Pre-Analytical Systems and Biosciences, Worldwide President of Diabetes Care, and Vice President/General Manager of Pharmaceutical Systems. Ms. Tharby has an Honors Bachelor of Business Administration from Wilfrid Laurier University in Waterloo, Ontario Canada.

Tom Adams

Chief Financial Officer

Tom joins KORU with medical device industry experience, coming from Integra Life Sciences, where he spent the last 10 years, with his most recent role there as Senior Director of Finance (FP&A).  Previous roles included Group Controller/Head of FP&A and Director of Finance (FP&A). Career highlights include establishing the Finance function for a newly created manufacturing division at Integra, which involved creating processes, setting up systems for reporting, management presentations and hiring a strong team. Tom recently led the financial analysis and negotiation to move Integra’s headquarters to Princeton, NJ, which this deal was recently awarded NJ’s 2019 office real estate deal of the year! He earned his Bachelor of Science in Business Administration-Accounting & Finance from Ohio State University. Tom brings extensive expertise and experience in building forecasts, budgets, modeling, and cost accounting that will support decision making and actions to help drive KORU’s growth.

Brian Case

Chief Technology Officer

Chris Pazdan

Senior Vice President, Operations

Chris joins the KORU team from Hillrom where he worked as the Vice President of Quality Assurance. In that role he was responsible for all quality functions for Hillrom’s largest manufacturing division. Prior to that role, Chris was the Vice President of QA/RA where he was responsible for enterprise-wide Design Assurance, Supplier Quality Assurance, Project Management Office, and Software. Chris’ proudest professional accomplishments include working with, leading, and helping build great teams. In addition to these efforts, he enjoys making a difference in the healthcare space and improving outcomes for patients and customers.

Chris received his bachelor’s degree in general engineering from the University of Illinois at Urbana-Champaign. He is a ASQ Certified Six Sigma Black Belt, ASQ Certified Quality Engineer and an ASQ Certified Quality Auditor.

Josh Bennett

Vice President and General Manager of Novel Therapies & International

Mr. Bennett’s experience spans healthcare product categories, care settings, and end markets, including medical devices / technology, pharmaceuticals, biologics, acute care, and home care. He has been responsible for growth in both U.S. and international markets.

He joins KORU Medical from Salter Labs, a global anesthesia and respiratory medical device manufacturer, where he served as Vice President Sales, Marketing, and Business Development beginning in 2012. Salter Labs merged with SunMed in 2019. Prior to this, he was with Baxter Healthcare, a Fortune 500 diversified global pharmaceutical and device manufacturer. At Baxter he focused on pharmaceuticals and biologics, with an emphasis on product and market development addressing nutrition, hydration, and hemophilia. Mr. Bennett began his career at PwC Consulting (now IBM Global Business Services).

Mr. Bennett received his MBA from the Kellogg School of Management at Northwestern University, where he was a Siebel Scholar and recipient of the Richard M. Clewett Award, and his BBA from Northwood University.

Rob Cannon

Vice President of Sales

Rob brings 30+ years of experience in sales across the healthcare industry with direct experience in home care, specialty pharmacy and with Plasma/Biologics.  Most recently, he served as the Vice President of Strategic Accounts for McKesson Alternate Pharmacy Solutions, where he led the strategy, planning, and implementation of effective sales and marketing strategies focused on the specialty pharma channel. Prior to that role, Rob was the Vice President of Sales for McKesson Plasma and Biologics, where he established and managed a sales team, and as the Senior Director for McKesson Alternate Site Pharmacy, where he spearheaded the development and execution of strategic programs enhancing pharmacy partnerships while also driving value and efficiency. Rob received his Bachelor of Science degree in chemistry from Fordham University. 

Brent Rutland

Vice President of Medical Affairs

Brent joins KORU with more than 25 years of experience in Medical Affairs.  Prior to joining KORU, Brent was with Baxter Healthcare as a Senior Medical Science Liaison and most recently with La Jolla Pharmaceutical Company as a Senior Director, Health Outcomes. During his tenure he has helped launch 7 vaccines, 4 drugs and 1 device.  Most notably, Brent aided Baxter in the launch of Hylenex for Pediatric SQ rehydration where he also helped build the Medical Affairs department.  Brent has received several awards throughout his career, with the most recent being the President’s Circle Award for Medical Affairs at La Jolla.  Brent holds a Bachelor of Science degree from Texas A&M University, an MBA in Global Management from the University of Houston and his Master of Public Health from the University of North Carolina in Epidemiology.